查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530783

2030 年儿科医疗保健市场预测：按产品类型、疾病类型、服务类型、治疗类型、最终用户和地区进行的全球分析

Pediatric Healthcare Market Forecasts to 2030 - Global Analysis By Product Type, Disease Type, Service Type, Treatment Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球儿科医疗保健市场规模将达到 144 亿美元，预计到 2030 年将达到 209 亿美元，预测期内复合年增长率为 6.4%。

儿科保健是指为儿童和青少年从婴幼儿到青春期提供的医疗保健和治疗。它包括广泛的服务，包括预防保健、疾病诊断和治疗、慢性病管理以及发育和行为评估。目的是维持年轻患者最佳的身体、情绪和心理健康。儿科保健专业人员接受过培训，可以满足不同发展阶段儿童的独特需求。

根据观察者研究基金会2021年12月发布的资料，印度约有2亿人营养不良。根据 Genworth 护理成本调查，私人住宅的专业护理服务平均费用为每天 290 美元，半私人房间的费用为每天 255 美元。

提高认识并让家长参与

市场意识的提高和家长的参与导致儿童健康结果的显着改善。家长们越来越了解预防保健、疫苗接种和疾病早期发现的重要性。这种积极主动的方法正在推动对小儿科服务、健康计划和专业护理的需求。此外，父母越来越多地参与有关孩子医疗保健的决策，要求高品质的医疗建议和整体照护选择。

小儿科短缺

小儿科的短缺限制了获得儿科专业护理的机会，并对市场产生了负面影响。这种短缺导致等待时间更长、诊断延迟，并增加了普通小儿科处理复杂病例的压力。因此，儿童可能无法得到最佳治疗，他们的健康状况可能会恶化。专家的短缺也给现有专家带来了压力，导致倦怠和护理品质下降。总的来说，它们阻碍了我们为年轻患者提供全面、及时的医疗保健的能力。

扩大医疗基础设施

扩大医疗基础设施将有助于解决市场上小儿科的短缺问题。透过建造更多的医院、诊所和培训设施，医疗保健系统可以提高教育和僱用小儿科的能力。这种扩展也将改善服务欠缺地区获得先进诊断工具和专业服务的机会。此外，远端医疗和数位健康平台可以扩大现有专家的执业范围，让更多的儿童获得所需的照护。

儿科医疗费用高

儿科医疗保健成本的上升给许多家庭造成了获得医疗服务的障碍，并对市场产生了负面影响。咨询、治疗和专业服务的费用不断上涨，给一些家长带来了经济压力，导致他们推迟或放弃对孩子进行必要的治疗。这可能会导致健康状况恶化和更多的急诊就诊，从长远来看，这可能会带来高昂的代价。经济负担也会阻碍父母寻求预防性医疗保健，进而影响孩子的整体健康和福祉。

COVID-19 的影响：

COVID-19 对儿科医疗保健市场产生了重大影响，扰乱了常规临床护理、免疫接种和选择性手术。对感染的恐惧导致医院就诊次数减少，重要治疗和预防服务也出现延误。此外，疫情也导致医疗资源紧张，并转移了儿科医疗服务的注意力和资金。整体影响包括儿童健康状况恶化以及医疗保健提供者和系统的压力增加。

预计在预测期内，慢性病领域将是最大的。

预计慢性病细分市场将成为预测期内最大的细分市场。慢性病的增加使医疗资源紧张，需要采取多学科的治疗方法。早期诊断、持续监测和协调护理对于有效管理这些疾病至关重要。慢性病的流行也凸显了製定全面医疗保健政策以及改善获得小儿科和支援服务的必要性。

行为治疗领域预计在预测期内复合年增长率最高

行为治疗产业预计在预测期内复合年增长率最高。人们对心理健康重要性的日益认识增加了对这些服务的需求。行为疗法帮助儿童培养应对技能、改善社交互动并有效管理行为。随着人们对心理健康问题的认识和接受程度的提高，儿科行为治疗市场不断扩大，为年轻患者提供量身定制的支持。

比最大的地区

在先进的医疗技术、优质的医疗基础设施和全面的保险体系的推动下，预计北美将在预测期内占据最大的市场占有率。该地区拥有完善的儿科专家和医疗机构网络，提供从预防性护理到专业治疗的全面服务。人们对儿科健康问题的认识不断提高，加上对小儿科研究和技术创新的投资不断增加，正在进一步推动市场成长。

复合年增长率最高的地区：

由于医疗基础设施的扩张，预计亚太地区在预测期内将保持最高的复合年增长率。各国政府和私营部门正在对医疗保健设施进行大量投资，包括儿童医院和诊所，以更有效地满足年轻患者的需求。改善获得医疗保健服务（包括免疫接种和例行检查）的机会正在改善儿童的整体健康。此外，远端医疗和数位健康解决方案的兴起使儿科护理变得更加容易，尤其是在偏远地区。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球儿科医疗保健市场：依产品类型

  • 诊断设备
  • 监控装置
  • 实验设备
  • 点滴帮浦
  • 儿科矫正器
  • 其他产品类型

第六章全球儿科医疗保健市场：依疾病类型

  • 感染疾病
  • 慢性疾病
  • 血液疾病
  • 遗传疾病
  • 呼吸系统疾病
  • 胃肠道疾病
  • 心血管疾病
  • 其他疾病类型

第七章全球儿科医疗保健市场：依服务类型

  • 住院治疗
  • 门诊治疗
  • 紧急服务
  • 復健服务
  • 家庭保健
  • 安宁疗护与临终关怀

第八章全球儿科医疗保健市场：依治疗类型

  • 药物和治疗
  • 手术和医疗程序
  • 放射治疗
  • 物理治疗及职能治疗
  • 行为疗法
  • 饮食和营养治疗
  • 基因治疗

第九章 全球儿科医疗保健市场：依最终用户分类

  • 医院
  • 小儿科诊所
  • 家庭护理设置
  • 调查机构
  • 其他最终用户

第10章全球儿科医疗保健市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Johnson & Johnson
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Eli Lilly and Company
  • AstraZeneca plc
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company Limited
  • Novo Nordisk A/S
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim GmbH
  • Hikma Pharmaceuticals PLC
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
Product Code: SMRC26895

According to Stratistics MRC, the Global Pediatric Healthcare Market is accounted for $14.4 billion in 2024 and is expected to reach $20.9 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Pediatric healthcare is the medical care and treatment provided to children and adolescents, from infancy through adolescence. It encompasses a wide range of services, including preventive health care, diagnosis and treatment of illnesses, management of chronic conditions, and developmental and behavioral assessments. The goal is to ensure the optimal physical, emotional, and mental health of young patients. Pediatric healthcare professionals are trained to address the unique needs of children at different stages of development.

According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. According to the Genworth Cost of Care Survey, skilled nursing services in private homes cost an average of $290 per day, while semi-private homes cost an average of $255.

Market Dynamics:

Driver:

Increasing awareness and parental involvement

Increasing awareness and parental involvement in the market have led to significant improvements in child health outcomes. Parents are now more informed about preventive care, vaccinations, and the importance of early detection of illnesses. This proactive approach has increased demand for pediatric services, wellness programs, and specialized care. Additionally, parents are actively engaging in decision-making regarding their child's healthcare, seeking quality medical advice and holistic care options.

Restraint:

Shortage of pediatric specialists

The shortage of pediatric specialists negatively impacts the market by limiting access to specialized care for children. This scarcity leads to longer wait times, delays in diagnosis and increased pressure on general pediatricians to manage complex cases. Consequently, children may experience suboptimal care and worsened health outcomes. The shortage also burdens existing specialists, leading to burnout and decreased quality of care. Overall, it hinders the ability to provide comprehensive and timely medical attention to young patients.

Opportunity:

Expanding healthcare infrastructure

Expanding healthcare infrastructure can help address the shortage of pediatric specialists in the market. By building more hospitals, clinics, and training facilities, healthcare systems can increase the capacity to educate and employ pediatric specialists. This expansion can also improve access to advanced diagnostic tools and specialized services in underserved areas. Additionally, telemedicine and digital health platforms can extend the reach of existing specialists, ensuring more children receive the necessary care.

Threat:

High cost of pediatric care

The high cost of pediatric care negatively impacts the market by creating barriers to access for many families. Rising costs for consultations, treatments, and specialized services can lead to financial strain, causing some parents to delay or forego necessary care for their children. This can result in worsening health conditions and increased emergency visits, which are more costly in the long run. The financial burden may also deter parents from seeking preventive care, ultimately affecting children's overall health and well-being.

Covid-19 Impact:

COVID-19 significantly impacted the pediatric healthcare market, causing disruptions in routine care, vaccinations, and elective procedures. Fear of exposure led to decreased hospital visits, delaying critical care and preventive services. Additionally, the pandemic strained healthcare resources, diverting attention and funding away from pediatric services. The overall impact includes worsened health outcomes for children and increased stress on healthcare providers and systems.

The chronic diseases segment is expected to be the largest during the forecast period

The chronic diseases is expected to be the largest during the forecast period. The rise in chronic illnesses strains healthcare resources and necessitates a multidisciplinary approach to treatment. Early diagnosis, continuous monitoring, and coordinated care are crucial for managing these conditions effectively. The prevalence of chronic diseases also highlights the need for comprehensive healthcare policies and improved access to pediatric specialists and support services.

The behavioral therapy segment is expected to have the highest CAGR during the forecast period

The behavioral therapy segment is expected to have the highest CAGR during the forecast period. The growing recognition of mental health's importance has increased demand for these services. Behavioral therapy helps children develop coping skills, improve social interactions, and manage behaviors effectively. As awareness and acceptance of mental health issues rise, the market for pediatric behavioral therapy continues to expand, offering tailored support for young patients.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by advanced medical technologies, high-quality healthcare infrastructure, and strong insurance coverage. The region has a well-established network of pediatric specialists and healthcare facilities, offering comprehensive services from preventive care to specialized treatments. Rising awareness of child health issues, coupled with increasing investment in pediatric research and innovation, further fuels market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to expanding healthcare infrastructure. Governments and private sectors are investing heavily in healthcare facilities, including children's hospitals and clinics, to address the needs of young patients more effectively. Enhanced access to healthcare services, including vaccinations and routine check-ups, is improving overall child health outcomes. Additionally, the rise of telemedicine and digital health solutions is making pediatric care more accessible, particularly in remote areas.

Key players in the market

Some of the key players in Pediatric Healthcare market include Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis International AG, Merck & Co., Inc., Sanofi, GlaxoSmithKline plc, AbbVie Inc., Eli Lilly and Company, AstraZeneca plc, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Bristol-Myers Squibb Company, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim GmbH, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd. and Mylan N.V.

Key Developments:

In April 2024, Novartis announced that the U.S. Food and Drug Administration (FDA) approved Lutathera(R) for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut NETs.

In April 2024, Pfizer Inc announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study for AdulTs at Higher Risk of Severe Illness),evaluating a single dose of ABRYSVO versus placebo in adults 18 to 59 years of age

Product Types Covered:

  • Diagnostic Devices
  • Monitoring Devices
  • Laboratory Equipment
  • Infusion Pumps
  • Pediatric Braces
  • Other Product Types

Disease Types Covered:

  • Infectious Diseases
  • Chronic Diseases
  • Hematological Disorders
  • Genetic Disorders
  • Respiratory Disorders
  • Gastrointestinal Disorders
  • Cardiovascular Disorders
  • Other Disease Types

Service Types Covered:

  • Inpatient Care
  • Outpatient Care
  • Emergency Services
  • Rehabilitation Services
  • Home Healthcare
  • Palliative and Hospice Care

Treatment Types Covered:

  • Medication and Therapeutics
  • Surgery and Medical Procedures
  • Radiation Therapy
  • Physical and Occupational Therapy
  • Behavioral Therapy
  • Dietary and Nutritional Therapy
  • Gene Therapy

End Users Covered:

  • Hospitals
  • Pediatric Clinics
  • Home Care Settings
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pediatric Healthcare Market, By Product Type

  • 5.1 Introduction
  • 5.2 Diagnostic Devices
  • 5.3 Monitoring Devices
  • 5.4 Laboratory Equipment
  • 5.5 Infusion Pumps
  • 5.6 Pediatric Braces
  • 5.7 Other Product Types

6 Global Pediatric Healthcare Market, By Disease Type

  • 6.1 Introduction
  • 6.2 Infectious Diseases
  • 6.3 Chronic Diseases
  • 6.4 Hematological Disorders
  • 6.5 Genetic Disorders
  • 6.6 Respiratory Disorders
  • 6.7 Gastrointestinal Disorders
  • 6.8 Cardiovascular Disorders
  • 6.9 Other Disease Types

7 Global Pediatric Healthcare Market, By Service Type

  • 7.1 Introduction
  • 7.2 Inpatient Care
  • 7.3 Outpatient Care
  • 7.4 Emergency Services
  • 7.5 Rehabilitation Services
  • 7.6 Home Healthcare
  • 7.7 Palliative and Hospice Care

8 Global Pediatric Healthcare Market, By Treatment Type

  • 8.1 Introduction
  • 8.2 Medication and Therapeutics
  • 8.3 Surgery and Medical Procedures
  • 8.4 Radiation Therapy
  • 8.5 Physical and Occupational Therapy
  • 8.6 Behavioral Therapy
  • 8.7 Dietary and Nutritional Therapy
  • 8.8 Gene Therapy

9 Global Pediatric Healthcare Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Pediatric Clinics
  • 9.4 Home Care Settings
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Pediatric Healthcare Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Pfizer Inc.
  • 12.3 Roche Holding AG
  • 12.4 Novartis International AG
  • 12.5 Merck & Co., Inc.
  • 12.6 Sanofi
  • 12.7 GlaxoSmithKline plc
  • 12.8 AbbVie Inc.
  • 12.9 Eli Lilly and Company
  • 12.10 AstraZeneca plc
  • 12.11 Astellas Pharma Inc.
  • 12.12 Takeda Pharmaceutical Company Limited
  • 12.13 Novo Nordisk A/S
  • 12.14 Bristol-Myers Squibb Company
  • 12.15 Amgen Inc.
  • 12.16 Gilead Sciences, Inc.
  • 12.17 Boehringer Ingelheim GmbH
  • 12.18 Hikma Pharmaceuticals PLC
  • 12.19 Teva Pharmaceutical Industries Ltd.
  • 12.20 Mylan N.V.

List of Tables

  • Table 1 Global Pediatric Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Pediatric Healthcare Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Pediatric Healthcare Market Outlook, By Diagnostic Devices (2022-2030) ($MN)
  • Table 4 Global Pediatric Healthcare Market Outlook, By Monitoring Devices (2022-2030) ($MN)
  • Table 5 Global Pediatric Healthcare Market Outlook, By Laboratory Equipment (2022-2030) ($MN)
  • Table 6 Global Pediatric Healthcare Market Outlook, By Infusion Pumps (2022-2030) ($MN)
  • Table 7 Global Pediatric Healthcare Market Outlook, By Pediatric Braces (2022-2030) ($MN)
  • Table 8 Global Pediatric Healthcare Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Pediatric Healthcare Market Outlook, By Disease Type (2022-2030) ($MN)
  • Table 10 Global Pediatric Healthcare Market Outlook, By Infectious Diseases (2022-2030) ($MN)
  • Table 11 Global Pediatric Healthcare Market Outlook, By Chronic Diseases (2022-2030) ($MN)
  • Table 12 Global Pediatric Healthcare Market Outlook, By Hematological Disorders (2022-2030) ($MN)
  • Table 13 Global Pediatric Healthcare Market Outlook, By Genetic Disorders (2022-2030) ($MN)
  • Table 14 Global Pediatric Healthcare Market Outlook, By Respiratory Disorders (2022-2030) ($MN)
  • Table 15 Global Pediatric Healthcare Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
  • Table 16 Global Pediatric Healthcare Market Outlook, By Cardiovascular Disorders (2022-2030) ($MN)
  • Table 17 Global Pediatric Healthcare Market Outlook, By Other Disease Types (2022-2030) ($MN)
  • Table 18 Global Pediatric Healthcare Market Outlook, By Service Type (2022-2030) ($MN)
  • Table 19 Global Pediatric Healthcare Market Outlook, By Inpatient Care (2022-2030) ($MN)
  • Table 20 Global Pediatric Healthcare Market Outlook, By Outpatient Care (2022-2030) ($MN)
  • Table 21 Global Pediatric Healthcare Market Outlook, By Emergency Services (2022-2030) ($MN)
  • Table 22 Global Pediatric Healthcare Market Outlook, By Rehabilitation Services (2022-2030) ($MN)
  • Table 23 Global Pediatric Healthcare Market Outlook, By Home Healthcare (2022-2030) ($MN)
  • Table 24 Global Pediatric Healthcare Market Outlook, By Palliative and Hospice Care (2022-2030) ($MN)
  • Table 25 Global Pediatric Healthcare Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 26 Global Pediatric Healthcare Market Outlook, By Medication and Therapeutics (2022-2030) ($MN)
  • Table 27 Global Pediatric Healthcare Market Outlook, By Surgery and Medical Procedures (2022-2030) ($MN)
  • Table 28 Global Pediatric Healthcare Market Outlook, By Radiation Therapy (2022-2030) ($MN)
  • Table 29 Global Pediatric Healthcare Market Outlook, By Physical and Occupational Therapy (2022-2030) ($MN)
  • Table 30 Global Pediatric Healthcare Market Outlook, By Behavioral Therapy (2022-2030) ($MN)
  • Table 31 Global Pediatric Healthcare Market Outlook, By Dietary and Nutritional Therapy (2022-2030) ($MN)
  • Table 32 Global Pediatric Healthcare Market Outlook, By Gene Therapy (2022-2030) ($MN)
  • Table 33 Global Pediatric Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 Global Pediatric Healthcare Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 35 Global Pediatric Healthcare Market Outlook, By Pediatric Clinics (2022-2030) ($MN)
  • Table 36 Global Pediatric Healthcare Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 37 Global Pediatric Healthcare Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 38 Global Pediatric Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.